Search results for "Practice"

showing 10 items of 2812 documents

A study of hurdles in mass treatment of schistosomiasis in KwaZulu-Natal, South Africa

2015

Background: It has been estimated that 700 million people worldwide and 5.2 million people in South Africa are in need of annual treatment for schistosomiasis. In accordance with the current policy the Department of Health (DoH) in KwaZulu-Natal province, South Africa, aimed to reach 75% treatment coverage in a mass treatment campaign (MTC) of schools in a schistosomiasis-endemic area.Methods: A cross-sectional study was designed to explore the implementation, coverage, challenges and limitations of a DoH MTC in a middle-income country. The study was conducted by exploring nurses’ and research team records, school enrolment lists and parental consent forms.Results: Slightly more than 10 000…

medicine.medical_specialtybusiness.industryRural healtheducationPublic Health Environmental and Occupational HealthAlternative medicineSchistosomiasismedicine.diseaseSurgeryFamily medicinemedicineMass treatmentHealth educationParental consentFamily PracticebusinessMass drug administrationKwazulu natalSouth African Family Practice
researchProduct

Orthotopic bladder augmentation and substitution.

1999

Orthotopic bladder augmentation or substitution using intestinal segments has become a standard procedure for many disorders that cause a loss of functional or anatomical bladder capacity. From the technical point of view, reservoir configuration by detubularizing the intestinal segments is the general practice. Various techniques exist, depending which types of segments and which techniques of ureteral implantation are used. Common problems include urinary incontinence, retention, metabolic disorders, and the possibility of secondary malignancies. As a result, research has been conducted into utilizing tissues other than intestine for bladder augmentation or substitution.

medicine.medical_specialtybusiness.industryUrologySubstitution (logic)StomachUrinary Reservoirs ContinentUrologyUrinary Bladder DiseasesBladder capacityUrinary incontinenceurologic and male genital diseasesStandard procedureIntestinesUrodynamicsText miningBladder augmentationGeneral practicemedicineQuality of LifeAnimalsHumansmedicine.symptomUreterbusinessCurrent opinion in urology
researchProduct

Available Instruments to Assess Pain in Infants

2021

Pain assessment in newborns and infants is challenging for clinicians. Although behavioral and behavioral-physiological scales are validated pain assessment instruments, their use in this age group has significant limitations. In this review, we summarize the methods currently available for assessing pain in neonates and infants. It is possible that these pain detection methods are also useful for assessing the quality of anesthesia and analgosedation in these populations. Further research should be aimed at confirming the usefulness of these tools in infants and identifying additional pain assessment options for clinical practice.

medicine.medical_specialtybusiness.industryinfantsMEDLINEInfant Newbornheart rate variabilityInfantPainPain detectionClinical PracticeProcedural PainPain assessmentAssessing PainPediatrics Perinatology and Child Healthmedicinepain assessmentHumansAnesthesiaIntensive care medicinebusinessskin conductance activityPain MeasurementNeoReviews
researchProduct

Comment on: Tocilizumab induces corticosteroid sparing in rheumatoid arthritis patients in clinical practice: reply

2015

Type de document : lettre à l'éditeur; International audience

medicine.medical_specialtybusiness.industrymedicine.drug_class[ SDV.SP.MED ] Life Sciences [q-bio]/Pharmaceutical sciences/Medicationmedicine.diseaseDermatologyRheumatologyClinical Practice[ SDV.MHEP.RSOA ] Life Sciences [q-bio]/Human health and pathology/Rhumatology and musculoskeletal systemchemistry.chemical_compoundTocilizumabchemistryRheumatologyRheumatoid arthritisInternal medicinemedicinePhysical therapyCorticosteroidPharmacology (medical)business
researchProduct

Cuantificación y tratamiento de la congestión en insuficiencia cardíaca: una visión clínica y fisiopatológica

2022

Renal sodium and water retention with resulting extracellular volume expansion and redistribution are hallmark features of heart failure syndromes. However, congestion assessment, monitoring, and treatment represent a real challenge in daily clinical practice. This document reviewed historical and contemporary evidence of available methods for determining volume status and discuss pharmacological aspects and pathophysiological principles that underlie diuretic use.

medicine.medical_specialtybusiness.industrymedicine.medical_treatmentmedicine.diseaseClinical PracticeNephrologyInternal medicineHeart failureExtracellular fluidmedicineCardiologyIntravascular volume statusDiureticbusinessNefrología
researchProduct

OP0089 METABOLIC SYNDROME IS COMMON AROUND THE TIME OF EARLY RHEUMATOID ARTHRITIS DIAGNOSIS AND ASSOCIATIONS VARY BY SEX AND MENOPAUSAL STATUS: RESUL…

2019

Background Prevalence studies of metabolic syndrome (MetS) in early rheumatoid arthritis (ERA) are sparse and estimates are variable. Differences by sex and menopausal status have not been formally assessed. Objectives We estimated prevalence and factors associated with MetS in ERA patients treated in routine practice settings. Variations by sex, and by menopausal status were also examined. Methods Cross-sectional data were analyzed from patients meeting 1987 or 2010 ACR/EULAR RA criteria enrolled in the Canadian Early Arthritis Cohort (CATCH) from January 2007-March 2017. CATCH is a prospective multicenter observational study of patients diagnosed and treated for early inflammatory arthrit…

medicine.medical_specialtybusiness.operationbusiness.industryFamily medicineCohortmedicinePrevalence studiesMallinckrodtEarly rheumatoid arthritisRoutine practicebusinessEarly arthritisOral Presentations
researchProduct

An unusual fatal case of overdose of Vinblastine and review of literature

2017

The pharmacological treatment of neoplasia is based on the use of chemotherapeutic substances. Chemotherapeutic agents can cause acute and chronic toxicity even at therapeutic doses. For this reason their overdose puts a patient’s life at severe risk. This work presents an unusual fatal case of overdose subsequent to an accidental massive administration of Vinblastine (90 mg instead of 9 mg), slow bolus (five minutes), to a 33-year-old woman who suffered from Hodgkin’s Lymphoma. The administration of the massive dose was due to a transcription error of the therapeutic treatment plan and miscommunication between the health professionals which caused the use of the wrong dose. The foren…

medicine.medical_specialtydeath; intoxication; medical malpractice; overdose; Vinblastine; 2734Therapeutic treatment2734Poison controlmedical malpracticeVinblastinePathology and Forensic MedicinePharmacological treatment03 medical and health sciences0302 clinical medicineBolus (medicine)intoxicationdeathmedicine030216 legal & forensic medicineIntensive care medicineChronic toxicitybusiness.industrymedicine.diseaseLymphomaVinblastineSurgery030220 oncology & carcinogenesisAccidentaloverdosebusinessmedicine.drug
researchProduct

Mortality in multiple sclerosis: a review

2008

This work was undertaken to evaluate studies on mortality caused by multiple sclerosis (MS), to evaluate if useful inferences can be drawn from survival studies that can be applied to clinical practice. A literature search was carried out to find epidemiological studies on MS prognosis, survival, mortality and causes of death relevant to our aim. The World Health Organization (WHO) reports on worldwide cause-specific mortality were also considered. Studies were evaluated according to the duration of the follow-up study, the year of publication and the methodology used. We evaluated MS survival from a methodological point of view and considered if time trends could be drawn from study result…

medicine.medical_specialtyeducation.field_of_studyPediatricsbusiness.industryMultiple sclerosisDisease durationPopulationmedicine.diseaseWorld healthClinical PracticeNeurologyOlder patientsEpidemiologymedicineNeurology (clinical)businessIntensive care medicineeducationCause of deathEuropean Journal of Neurology
researchProduct

Assessment of the health care system functioning in Poland in light of the analysis of the indicators of the hospital emergency department (ED) and p…

2019

Background In the last three decades, in developed countries, the number of patients reporting to hospital emergency departments has dramatically increased. The number of visits to EDs can be an important indicator of the quality of primary health care. Objectives To analyse: 1) the frequency of admissions to EDs, 2) the type and number of medical procedures performed in EDs, and 3) the type and number of services provided by PHC in the Kedzierzyn-Kozle district. Material and methods A retrospective analysis of the statistical data regarding services provided by PHC in the Kedzierzyn-Kozle district within the National Health Fund (NHF) and data from the hospital emergency department in Kedz…

medicine.medical_specialtyemergency servicebusiness.industrydelivery of health carelcsh:RPrimary health careprofessional practice gapscomprehensive health carelcsh:MedicineGeneral Medicineprimary health careFamily medicineHealth caremedicinehospitalbusinessFamily Medicine & Primary Care Review
researchProduct

Triglycerides, HDL cholesterol and atherogenic dyslipidaemia in the 2019 European guidelines for the management of dyslipidaemias.

2019

In general, both European and American clinical guidelines have addressed the management of atherogenic dyslipidaemia in an unconvincing and even superficial way, largely because of the available therapeutic limitations. Consequently, this type of dyslipidaemia is underdiagnosed, under-treated, and under-controlled. Given the recent presentation of the 2019 guidelines of the European Atherosclerosis Society and the European Society of Cardiology on the management of dyslipidaemias, it seems appropriate to examine its position with respect to atherogenic dyslipidaemia and/or its main components, the increase in triglyceride-rich lipoproteins, and the decrease of high-density lipoprotein chol…

medicine.medical_specialtyendocrine system diseaseschemistry.chemical_compoundTriglycerides/HDL CholesterolInternal medicineMedicineHumanscardiovascular diseasesTriglyceridesGeneral Environmental ScienceLipoprotein cholesterolDyslipidemiasbusiness.industryCholesterolCholesterol HDLGeneral Engineeringnutritional and metabolic diseasesAtherosclerosisEuropechemistryPractice Guidelines as TopicCardiologyEuropean atherosclerosis societyGeneral Earth and Planetary Scienceslipids (amino acids peptides and proteins)businessClinica e investigacion en arteriosclerosis : publicacion oficial de la Sociedad Espanola de Arteriosclerosis
researchProduct